Zoya Enakshi Ali
Research Subjects
Zoya Enakshi Ali has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- George Liperis
Westmead Fertility Centre, Institute of Reproductive Medicine, University of Sydney , Westmead, NSW
5 shared publications - Juan Jose Fraire-Zamora
EUGIN Group, R&D , Barcelona
5 shared publications - Omar Farhan Ammar
Department of Obstetrics and Gynaecology, College of Medicine, University of Anbar, Ramadi, Iraq
4 shared publications - Claudia Massarotti
University of Genova, Dipartimento di Neuroscienze- Riabilitazione- Oftalmologia- Genetica e Scienze Materno-Infantili (DINOGMI Department)
3 shared publications - Mina Mincheva
Independent Researcher , London
3 shared publications - Munevver Serdarogullari
Department of Histology and Embryology, Faculty of Medicine, Cyprus International University , Northern Cyprus via Mersin
3 shared publications
Latest Publications
- 26 September 2025
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 40 (11) , 2202-2206
Rethinking decision-making support in elective egg freezing: complementing counselling with decision aids
- 26 September 2025
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 40 (11) , 2202-2206
Rethinking decision-making support in elective egg freezing: complementing counselling with decision aids
- 21 July 2025
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 40 (9) , 1807-1811
Advancing fertility education to address changing societal and demographic trends
- 21 July 2025
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 40 (9) , 1807-1811
Advancing fertility education to address changing societal and demographic trends
- Open Access
- 2 March 2025
- Published by Wiley
Emerging Trends in Preconception Behaviours: A Cross-Sectional Analysis of Lifestyle Factors in 235,311 UK-Based Women
Objective To assess preconception lifestyle behaviours between individuals actively trying to conceive (TTC) and planning for future pregnancies (PFF). Design Retrospective cross-sectional study. Setting UK-based women. Population 235,311 women who completed an online reproductive health questionnaire between September 2020 and November 2024. Methods Self-reported data on reproductive intent as well as smoking, vaping, alcohol, and drug use were analysed. Logistic regression models adjusted for age, BMI, and lifestyle factors compared behavioural differences between TTC and PFF groups. Main Outcome Measures Prevalence of modifiable lifestyle factors (smoking, vaping, alcohol, and drug use) in TTC vs. PFF groups, stratified by age and TTC duration. Results TTC individuals smoked more than PFF individuals (9.1% vs. 7.3%; aOR = 1.76, 95% CI: 1.68–1.84, p < 0.001). Although vaping was more prevalent among PFF individuals (13.7% vs. 12.3%), TTC individuals had higher adjusted odds of vaping (aOR = 1.14, 95% CI: 1.10–1.18, p < 0.001). TTC individuals were more likely to abstain from alcohol (48.8% vs. 30.5%, p 12 months. Conclusions Findings show continued engagement in high-risk behaviours despite TTC, underscoring the need for targeted interventions, particularly vaping cessation and age-specific counselling, to mitigate risks earlier in the reproductive timeline and improve fertility outcomes.
- 2 March 2025
- Published by Wiley
Open AccessEmerging Trends in Preconception Behaviours: A Cross-Sectional Analysis of Lifestyle Factors in 235,311 UK-Based Women
Objective To assess preconception lifestyle behaviours between individuals actively trying to conceive (TTC) and planning for future pregnancies (PFF). Design Retrospective cross-sectional study. Setting UK-based women. Population 235,311 women who completed an online reproductive health questionnaire between September 2020 and November 2024. Methods Self-reported data on reproductive intent as well as smoking, vaping, alcohol, and drug use were analysed. Logistic regression models adjusted for age, BMI, and lifestyle factors compared behavioural differences between TTC and PFF groups. Main Outcome Measures Prevalence of modifiable lifestyle factors (smoking, vaping, alcohol, and drug use) in TTC vs. PFF groups, stratified by age and TTC duration. Results TTC individuals smoked more than PFF individuals (9.1% vs. 7.3%; aOR = 1.76, 95% CI: 1.68–1.84, p < 0.001). Although vaping was more prevalent among PFF individuals (13.7% vs. 12.3%), TTC individuals had higher adjusted odds of vaping (aOR = 1.14, 95% CI: 1.10–1.18, p < 0.001). TTC individuals were more likely to abstain from alcohol (48.8% vs. 30.5%, p 12 months. Conclusions Findings show continued engagement in high-risk behaviours despite TTC, underscoring the need for targeted interventions, particularly vaping cessation and age-specific counselling, to mitigate risks earlier in the reproductive timeline and improve fertility outcomes.
- 27 December 2024
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 40 (2) , 398-404
Add-ons in medically assisted reproduction: from evidence to clinical practice
- 27 December 2024
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 40 (2) , 398-404
Add-ons in medically assisted reproduction: from evidence to clinical practice
- Open Access
- 3 October 2024
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 39 (12) , 2873-2877
Role, benefits, and risks of AMH testing for non-ART related indications
The March ESHRE Journal Club discussion focused on a study by Copp et al. ( 2023) on the advantages and disadvantages of AMH testing, the misinterpretation of AMH levels outside an infertility treatment, the variability of AMH levels in different populations, and the impact of misleading media portrayal of DTC AMH tests on consumers. AMH, Anti-Müllerian hormone; DTC, direct-to-consumer.
- 3 October 2024
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 39 (12) , 2873-2877
Open AccessRole, benefits, and risks of AMH testing for non-ART related indications
The March ESHRE Journal Club discussion focused on a study by Copp et al. ( 2023) on the advantages and disadvantages of AMH testing, the misinterpretation of AMH levels outside an infertility treatment, the variability of AMH levels in different populations, and the impact of misleading media portrayal of DTC AMH tests on consumers. AMH, Anti-Müllerian hormone; DTC, direct-to-consumer.
- Open Access
- 21 June 2023
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 38 (8) , 1649-1653
Balancing the scales: the interplay of diet, exercise, GLP-1 receptor agonists, and obesity in shaping male reproductive health
The January 2023 Journal Club was dedicated to a study by Andersen et al. (2022), inspiring discussion about the effects of diet-induced weight loss on male infertility, the long-term strategies to maintain improved semen parameters following weight loss and GLP-1 receptor agonist medications as a strategy for clinical management of obesity-related infertility. Figure created with BioRender. GLP-1: glucagon-like peptide-1, GLP-1 RA: glucagon-like peptide-1 receptor agonist, HPG axis: Hypothalamic-pituitary-gonadal axis.
- 21 June 2023
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 38 (8) , 1649-1653
Open AccessBalancing the scales: the interplay of diet, exercise, GLP-1 receptor agonists, and obesity in shaping male reproductive health
The January 2023 Journal Club was dedicated to a study by Andersen et al. (2022), inspiring discussion about the effects of diet-induced weight loss on male infertility, the long-term strategies to maintain improved semen parameters following weight loss and GLP-1 receptor agonist medications as a strategy for clinical management of obesity-related infertility. Figure created with BioRender. GLP-1: glucagon-like peptide-1, GLP-1 RA: glucagon-like peptide-1 receptor agonist, HPG axis: Hypothalamic-pituitary-gonadal axis.